Skip to content
healthcare.dev

Bupropion Hydrochloride (XL)

NDC 69097-875, bupropion hydrochloride, tablet, extended release, from CIPLA USA INC.,.

Product NDC
69097-875
Status
Listed
Labeler
CIPLA USA INC.,
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206556
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-875 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE150 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
69097-875-026909708750230 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-02)
69097-875-056909708750590 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-05)
69097-875-1269097087512500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c2cf79d7-1aba-4391-980b-5e218781f7c6
  • NADAC price for package 69097087505

    GET /v1/drugs/nadac/69097087505

Use it

Look up 69097-875 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-875 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-875. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.